Fulcrum Therapeutics Inc (NASDAQ:FULC)

8.64
BATS BZX Real-Time Price
As of 10:43am ET
 +0.17 / +2.01%
Today’s Change
4.37
Today|||52-Week Range
22.96
-48.08%
Year-to-Date
Dyne Therapeutics on deck for IPO
Aug 26 / Seeking Alpha - Paid Partner Content
 

Today’s Trading

Previous close8.47
Today’s open8.49
Day’s range8.44 - 8.64
Volume226
Average volume (3 months)157,045
Market cap$210.6M
Data as of 10:43am ET, 09/18/2020

Growth & Valuation

Earnings growth (last year)-384.74%
Earnings growth (this year)+66.05%
Earnings growth (next 5 years)+2.87%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.99

Competitors

 Today’s
change
Today’s
% change
EVLOEvelo Biosciences In...+0.06+1.21%
SMMTSummit Therapeutics ...0.000.00%
LQDALiquidia Technologie...+0.22+3.68%
ABUSArbutus Biopharma Co...+0.04+1.34%
Data as of 10:45am ET, 09/18/2020

Financials

Next reporting dateNovember 12, 2020
EPS forecast (this quarter)-$0.66
Annual revenue (last year)$0.00
Annual profit (last year)-$82.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts